Kiora Pharmaceuticals (KPRX) Misses Q3 EPS by 81c

Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q3 EPS of ($0.81).

For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Tango Therapeutics Inc. (TNGX) PT Raised to $68 at H.C. Wainwright